DAVENPORT & Co LLC

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Investment type: Debt / NOTE 1.250% 5/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	0%	$959,589	10,000	0		9595.89%	Q4 2025
30 Sep 2025	0.01%	0%	$948,000	10,000	0		9480.0%	Q3 2025
30 Jun 2025	0.01%	0%	$943,750	10,000	0		9437.5%	Q2 2025
31 Mar 2025		0%	$946,534	10,000	0		9465.34% ^*	Q1 2025
31 Dec 2024		0%	$931,493	10,000	0		9314.93% ^*	Q4 2024
30 Sep 2024		0%	$952,930	10,000	0		9529.3% ^*	Q3 2024
30 Jun 2024		0%	$960,172	10,000	0		9601.72% ^*	Q2 2024
31 Mar 2024		0%	$994,300	10,000	0		9943.0% ^*	Q1 2024
31 Dec 2023		0%	$10,269	100	0		10269.0% ^*	Q4 2023
30 Sep 2023	0.01%	+0.01%	$994,160	10,000	+10,000	NEW	9941.6%	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.